ARCHIVES

Q & A: NCI’s Doroshow Says Phase I Program Will Stress Correlative Studies for Small Biotech Firms

This article is from The Cancer Letter archive.

Vol. 38 No. 14 | April 6, 2012

Download PDF Visit The Full Archive

Related Articles

Coooperative Groops Announce Two Sets of Mergers: NSABP, RTOG Form Alliance; CALGB, NCCTG & ACOSOG Seek to Become Single Group

March 11, 2011

Prostate Ultrasound Markers Concepts Approved by BSC

October 3, 1986

TGen’s Trent To Lead Van Andel Institute

February 13, 2009

Researchers Identify Subtype Demonstrating Angiogenesis

February 24, 2012

Hilton Head, SC, Physician’s Files Subpoenaed By FBI

March 18, 1994

FDA Sets High Bar for Prevention Agents as ODAC Votes Down Proscar And Avodart

December 3, 2010